Human papilloma virus (HPV) is a common virus that can cause genital warts and certain cancers. The HPV vaccine is effective in preventing many HPV-associated diseases, however, vaccination rates suggest many remain unprotected. This study examined successful strategies used by physicians to improve HPV vaccination rates. Providers with above average vaccination rates were identified. A represe...

We present a transmission dynamic model that can assess the epidemiologic consequences and cost-effectiveness of alternative strategies of administering a prophylactic quadrivalent (types 6/11/16/18) human papillomavirus (HPV) vaccine in a setting of organized cervical cancer screening in the United States. Compared with current practice, vaccinating girls before the age of 12 years would reduc...

To assess the epidemiological and economic impact of alternative quadrivalent human papillomavirus (HPV) vaccine strategies in Norway, we adapted a previously published dynamic transmission model. Vaccination of girls and women aged 12-24 years reduced the incidence of HPV 6/11/16/18-related genital warts, cervical intraepithelial neoplasia and cervical cancer by 94, 92 and 92% by year 100, res...

Sir, Human papillomavirus (HPV) is the causative agent of certain benign and malignant tumours. HPV subtypes 6 and 11 cause approximately 90% of cases of genital warts (the most common sexually transmitted disease) (1, 2) and virtually all cases of recurrent respiratory papillomatosis (3, 4). They are classified as low-risk for carcinogenesis, whilst the high-risk subtypes, such as 16 and 18, c...

At present two prophylactic human papilloma virus (HPV) vaccines are commercially available. The tetravalent vaccine comprised of four VPH types (6, 11, 16, and 18) distributed in the national program in Colombia and the bivalent vaccine comprised of VPH types 16 and 18, respectively. Types 16 and 18 are accountable for 70% of cervical cancer, most vulva, vagina, penis, anus and one third of or...

Actas Dermosifiliogr. 2008;99:157-69 163 Genital warts are the most frequently observed form of HPV infection and, to date, only 1 double-blind phase II clinical trial has been published on the use of topical cidofovir.9 In that trial, 47% of the 19 patients in the group treated with cidofovir had a complete response with no important side effects reported. This percentage is similar to those o...

OBJECTIVE To examine parents' preferences and willingness-to-pay (WTP) for HPV vaccines. METHODS A discrete choice experiment (DCE) was used. Parents with at least one daughter aged 9-13 years residing in Songkhla province were asked to choose one alternative from each DCE choice set describing HPV vaccines by four attributes, including cervical cancer risk reduction, genital warts risk reduc...

Actas Dermosifiliogr. 2008;99:157-69 163 Genital warts are the most frequently observed form of HPV infection and, to date, only 1 double-blind phase II clinical trial has been published on the use of topical cidofovir.9 In that trial, 47% of the 19 patients in the group treated with cidofovir had a complete response with no important side effects reported. This percentage is similar to those o...

Background and aim: Warts are the most common clinical presentation of human papilloma virus infection of human skin and mucosa. They are more common on hand, foot, face and genital area. They are benign skin colour lesions with different clinical forms. There is no specific treatment for them. In this trial the therapeutic effect of intralesional injection of bleomycin and cryotherapy on...

Introduction. In recent years, there has been an increase in the number of cases anogenital warts, with localization urethra, which present significant difficulties management tactics due to high frequency relapses, progression clinical manifestations and damage underlying tissues. According a systematic review including PubMed EMBASE data, severe warts may be associated decrease local systemic...